Research
HC Wainwright Initiates Generate Biomedicines at Buy With $16 Price Target
Generate Biomedicines (GENB) has an average rating of buy and mean price target of $25, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$GENB
